Rafi Haner DİRESKENELİ, Güzide Nevsun İNANÇ, Safiye Atlas Tulin ERGUN, Gonca MUMCU, Uğur ALPAR, Fatma ÖNER ALİBAZ, Ali Uğur ÜNAL, Zeynep ERTÜRK, Fadime LEHİMCİ, Özlem FİDAN, Hülya GÜK

The assessment of work productivity and activity impairment in Behçet's disease

Background/aim: The aim of this study was to assess the relationships between the course of Behçet s disease (BD), disease-specific fears, and work productivity and activity impairment. Materials and methods: In this cross-sectional study, 110 consecutive BD patients were included. The Work Productivity and Activity Impairment questionnaire was used. Results: In the group of employed patients, 30.41% had missed work during the previous week. The mean percentages of daily activity impairment were higher in patients with musculoskeletal involvement (39.81 ± 33.61%) compared to those without (23.48 ± 32.45%) (P = 0.008). A greater decrease in working hours was observed in patients with eye involvement (45.52 ± 15.29 h) compared to those without (54.15 ± 15.29 h) (P = 0.007). More of the male patients (67.8%) were afraid of losing their jobs compared to females (30%) (P = 0.000). Conclusion: The highest levels of lost productivity and the most severe effects on daily life are consequences of eye and musculoskeletal involvement in the study population. More effective therapeutic approaches are required to improve the working lives of patients with BD. Moreover, male patients had a higher fear of losing their jobs, suggesting a match between the expected clinical course and the predictions of BD patients.

PDF

___

1. Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc 2014; 11: 1433-1438.
2. Halpin D, Hyland M, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves C, Hawkins A, Seamark D. Understanding fear and anxiety in patients at the time of an exacerbation of chronic obstructive pulmonary disease: a qualitative study. JRSM Open 2015; 6: 2054270415614543.
3. Ziarko M, Mojs E, Piasecki B, Samborski W. The mediating role of dysfunctional coping in the relationship between beliefs about the disease and the level of depression in patients with rheumatoid arthritis. Sci World J 2014; 2014: 585063.
4. Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA et al. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research. J Rheumatol 2014; 41: 165-176.
5. Besen E, Pranksy G. Assessing the relationship between chronic health conditions and productivity loss trajectories. J Occup Environ Med 2014; 56: 1249-1257.
6. Detaille SI, Heerkens YF, Engels JA, van der Gulden JW, van Dijk FJ. Common prognostic factors of work disability among employees with a chronic somatic disease: a systematic review of cohort studies. Scan J Work Env Hea 2009; 35: 261-281.
7. Allaire S, Wolfe F, Niu J, LaValley MP, Zhang B, Reisine S. Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort. Arthritis Rheum 2009; 61: 321-328.
8. Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007; 34: 481-487.
9. Backman CL, Kennedy SM, Chalmers A, Singer J. Participation in paid and unpaid work by adults with rheumatoid arthritis. J Rheumatol 2004; 31: 47-56.
10. Cooksey R, Husain MJ, Brophy S, Davies H, Rahman MA, Atkinson MD, Phillips CJ, Siebert S. The cost of ankylosing spondylitis in the UK using linked routine and patient-reported survey data. PLoS One 2015; 10: e0126105.
11. Page RL, Ghushchyan V, Gifford B, Read RA, Raut M, Bookhart BK, Naim AB, Damaraju CV, Nair KV. Hidden costs associated with venous thromboembolism: impact of lost productivity on employers and employees. J Occup Environ Med 2014; 56: 979- 985.
12. Walsh JA, McFadden ML, Morgan MD, Sawitzke AD, Duffin KC, Krueger GG, Clegg DO. Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol 2014; 41: 1670-1674.
13. van der Weijden MA, Boonen A, van der Horst-Bruinsma IE. Problems in work participation and resource use should not be underestimated in patients with early spondyloarthritis. J Rheumatol 2014; 41: 2413-2420.
14. Boonen A, Boone C, Albert A, Mielants H. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors. J Rheumatol 2015; 42: 93-100.
15. Garris C, Oglesby A, Sulcs E, Lee M. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus 2013; 22: 1077-1086.
16. Heelan K, Hitzig SL, Knowles S, Drucker AM, Mittmann N, Walsh S, Shear NH. Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses. J Cutan Med Surg 2015; 19: 546-554.
17. Song X, Quek RG, Gandra SR, Cappell KA, Fowler R, Cong Z. Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures. BMC Health Serv Res 2015; 15: 245.
18. Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity. Dermatol Online J 2015; 21: 13030/qt1x16v3dg.
19. Adepoju OE, Bolin JN, Ohsfeldt RL, Phillips CD, Zhao H, Ory MG, Forjuoh SN. Can chronic disease management programs for patients with type 2 diabetes reduce productivity-related indirect costs of the disease? Evidence from a randomized controlled trial. Popul Health Manag 2014; 17: 112-120.
20. Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther 2010; 12: R177.
21. Mehta P, Ambrose N, Haskard DO. Work-related disability in Behçets syndrome: a British case series. Clin Exp Rheumatol 2014; 32 (4 Suppl. 84): S173-174.
22. Alibaz-Oner F, Mumcu G, Kubilay Z, Ozen G, Celik G, Karadeniz A, Can M, Oner SY, Inanc N, Atagunduz P et al. Unmet need in Behcets disease: most patients in routine follow-up continue to have oral ulcers. Clin Rheumatol 2014; 33: 1773- 1776.
23. Merkel PA, Aydin SZ, Boers M, Cornell C, Direskeneli H, Gebhart D, Hatemi G, Luqmani R, Matteson EL, Milman N et al. Current status of outcome measure development in vasculitis. J Rheumatol 2014; 41: 593-598.
24. Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici H. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol 2014; 41: 599-612.
25. Mumcu G, Sur H, Inanc N, Karacayli U, Cimilli H, Sisman N, Ergun T, Direskeneli H. A composite index for determining the impact of oral ulcer activity in Behcets disease and recurrent aphthous stomatitis. J Oral Pathol Med 2009; 38: 785-791.
26. Mumcu G, Hayran O, Ozalp DO, Inanc N, Yavuz S, Ergun T, Direskeneli H. The assessment of oral health-related quality of life by factor analysis in patients with Behcets disease and recurrent aphthous stomatitis. J Oral Pathol Med 2007; 36: 147- 152.
27. Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U, Yavuz S, Sur H, Atalay T, Direskeneli H. Oral health related quality of life is affected by disease activity in Behçets disease. Oral Dis 2006; 12: 145-151.
28. Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O, Yildiz F, Kimyon G, Yilmazer B, Gerdan V et al. Impaired quality of life, disability and mental health in Takayasus arteritis. Rheumatology 2013; 52: 1898-1904.
29. Ilhan B, Can M, Alibaz-Oner F, Yılmaz-Oner S, Polat-Korkmaz O, Ozen G, Mumcu G, Maradit-Kremers H, Direskeneli H. Fatigue in patients with Behcets syndrome: relationship with quality of life, depression, anxiety, disability and disease activity. Int J Rheum Dis (in press).
30. International Study Group for Behçets Disease. Criteria for diagnosis of Behcets disease. Lancet 1990; 335: 1078-1080.
31. Krause I, Mader R, Sulkes J, Paul M, Uziel Y, Adawi M, Weinberger A. Behçets disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-1036.
32. Resmi Gazete. İş Kanunu. Sayı 25134, 10/6/2003. Ankara, Turkey: T.C. Başbakanlık; 2003 (in Turkish).
33. Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H. A cost analysis of Behcets syndrome in Turkey. Rheumatology 2007; 46: 678-682 (in Turkish).
34. Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache R 2014; 18: 385.
35. Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis 2014; 9: 289-300.
36. Schofield DJ, Shrestha RN, Cunich M, Tanton R, Kelly S, Passey ME, Veerman LJ. Lost productive life years caused by chronic conditions in Australians aged 45-64 years, 2010-2030. Med J Australia 2015; 203: 260.
37. Rank MR, Hirschl TA. The risk of developing a work disability across the adulthood years. Disability Health J 2014; 7: 189- 195.
38. Leijten FR, van den Heuvel SG, Ybema JF, van der Beek AJ, Robroek SJ, Burdorf A. The influence of chronic health problems on work ability and productivity at work: a longitudinal study among older employees. Scan J Work Env Hea 2014; 40: 473- 482.
39. van Boven JF, Chavannes NH, van der Molen T, Rutten-van Molken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Resp Med 2014; 108: 103-113.